Hematological toxicity of doxorubicin-containing protocols in dogs with spontaneously occurring malignant tumors

Journal of the American Animal Hospital Association

Volumn 36, Issue 5, 2000, Pages 422-426

  Ahaus, Elizabeth A ^a   Couto, C Guillermo ^a   Valerius, Karina D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; VINCRISTINE;

ANIMAL MODEL; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; DOG DISEASE; LEUKOCYTE COUNT; LYMPHOMA; NEOPLASM; NONHUMAN; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 0033813423     PISSN: 05872871     EISSN: None     Source Type: Journal    
DOI: 10.5326/15473317-36-5-422     Document Type: Article

References (13)

1. Ogilvie GK. Chemotherapy. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. WB Saunders, 1996:70-86.
2. Doroshow JH. Anthracyclines and anthracenediones. In: Chabner BA, Longo DL, eds. Cancer chemotherapy and hiotherapy: principles and practice. 2nd ed. Philadelphia: Lippincott-Raven, 1996:409-34.
3. Couto CG. Complications of anticancer chemotherapy. Vet Clin N Am 1990;20:1037-54.
4. Hammer AS, Couto CG, Filppi J, Getzy D, Shank KA. Efficacy and toxicity of VAC chemotherapy (vincristine, adriamycin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Int Med 1991;5:160-6.
5. Sorenmo KU, Jeglum KA, Helfand SC. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Int Med 1993;7:370-6.
6. Price GS, Page RL, Fischer BM, Levine JF, Gerig TM. Efficacy and toxicity of doxorubicin and cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. J Vet Int Med 1991;5:259-62.
7. Stone MS, Goldstein MA, Cotter SM. Comparison of two protocols for induction of remission in dogs with lymphoma. J Am Anim Hosp Assoc 1991;27:315-21.
8. Myers NC, Moore AS, Rand WM, Gliatto J, Cotter SM. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Int Med 1997;11:333-9.
9. Keller ET, MacEwen EG, Rosenthal RC, Helfand SC, Fox LE. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Int Med 1993;7:289-95.
10. Postorino NC, Susaneck SJ, Withrow SJ, Macy DW, Harris C. Single agent therapy with adriamycin for canine lymphosarcoma. J Am Anim Hosp Assoc 1989;25:221-5.
11. Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). J Am Vet Med Assoc 1997;210:512-6.
12. Hammer AS, Couto CG, Ayl RD, Shank KA. Treatment of tumor-bearing dogs with actinomycin D. J Vet Int Med 1994;8:236-9.
13. Couto CG. Complications of cancer chemotherapy. In: Nelson R, Couto CG, eds. Small animal internal medicine. St. Louis: Mosby, 1998:1108-17.